Yumanity Therapeutics’s Merger With Proteostasis Therapeutics, Inc.

Ambrogio Visconti

Goodwin Procter LLP advised Yumanity Therapeutics on the deal. Cooley advised Proteostasis Therapeutics on the deal. Yumanity Therapeutics and Proteostasis Therapeutics, Inc. (Nasdaq: PTI) announced that…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here